Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry [4]

Histopathology

Volumn 44, Issue 3, 2004, Pages 301-302

  Dagrada, G P ^a   Negri, T ^a   Tamborini, E ^a   Pierotti, M A ^a   Pilotti, S ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CLINICAL ARTICLE; CLINICAL GENETICS; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LETTER; ONCOGENE NEU; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND DUCT;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PAROTID NEOPLASMS; PRECIPITIN TESTS; RECEPTOR, ERBB-2; SALIVARY DUCTS; TUMOR MARKERS, BIOLOGICAL;

EID: 1642483439     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.01781.x     Document Type: Letter

References (5)

1. Skalova A, Starek I, Vanecek T et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology 2003; 42; 348-356.
2. Dagrada GP, Mezzelani A, Alasio L et al. HER-2/neu assessment in primary chemotherapy treated breast carcinoma: no evidence of gene profile changing. Breast Cancer Res. Treat. 2003; 80; 207-214.
3. Pauletti G, Godolphin W, Press MF et al. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 1996; 13; 63-72.
4. Mitelman F. Catalog of chromosome aberrations in cancer, 5th ed. New York: Wiley-Liss, 1994.
5. Vogel CL, Cobleigh MA, Tripathy D et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 2002; 20; 719-726.